Chemistry:DODB
DODB, also known as 2,5-dimethoxy-4,6-dibromoamphetamine or as 6-bromo-DOB, is a psychedelic drug of the phenethylamine, amphetamine, and DOx families related to DOB.[1] It is the 6-bromo derivative of DOB and the 4,6-dibromo derivative of 2,5-dimethoxyamphetamine (2,5-DMA; DOH).[1] The drug has a dose range of 5 to 8 mg orally and a duration of 12 to 20 hours.[1] For comparison, DOB has a dose of 1 to 3 mg and a duration of 18 to 30 hours.[1] DODB is described as having largely the same effects as DOB.[1] However, it is said that the drug may have somewhat greater visual effects than DOB and that its physical side effects appear to be less pronounced than those of DOB.[1] DODB was synthesized and tested by P. Rausch in the 1990s or 2000s.[1][2] It was described in the scientific literature by Daniel Trachsel in 2013, who cited personal communication with Rausch as the source for the information.[1]
See also
- DOx (psychedelics)
- 2C-DB
- DODC
- 2-Bromomescaline
- 2-Bromo-TMA
References
- ↑ 1.0 1.1 1.2 1.3 1.4 1.5 1.6 1.7 (in de) Phenethylamine: von der Struktur zur Funktion. Nachtschatten-Science (1 ed.). Solothurn: Nachtschatten-Verlag. 2013. pp. 921. ISBN 978-3-03788-700-4. OCLC 858805226. https://books.google.com/books?id=-Us1kgEACAAJ.
- ↑ (in German, English) Jahrbuch des Europäischen Collegiums für Bewußtseinsstudien: 1995. 4. Berlin: VWB. January 1995. ISBN 3861354071. OCLC 28636362.
External links
 |  |
